Patients with pulmonary arterial hypertension languishing on monotherapy: study
PBS restrictions are hampering best practice, say researchers
One in six Australians with pulmonary arterial hypertension remain on a single drug despite the severity of their disease meriting combination therapy, a study shows.
The lack of PBS subsidy for combination therapy may explain the apparent failure to prescribe it regardless of the recommendations in international guidelines, the authors write in Heart, Lung and Circulation.
In a cross-sectional study of 1046 patients from the Pulmonary Hypertension Society